1. Home
  2. KELYB vs KMDA Comparison

KELYB vs KMDA Comparison

Compare KELYB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KELYB
  • KMDA
  • Stock Information
  • Founded
  • KELYB 1946
  • KMDA 1990
  • Country
  • KELYB United States
  • KMDA Israel
  • Employees
  • KELYB N/A
  • KMDA N/A
  • Industry
  • KELYB Professional Services
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • KELYB Consumer Discretionary
  • KMDA Health Care
  • Exchange
  • KELYB Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • KELYB 426.3M
  • KMDA 399.7M
  • IPO Year
  • KELYB N/A
  • KMDA N/A
  • Fundamental
  • Price
  • KELYB $12.59
  • KMDA $7.77
  • Analyst Decision
  • KELYB
  • KMDA Strong Buy
  • Analyst Count
  • KELYB 0
  • KMDA 2
  • Target Price
  • KELYB N/A
  • KMDA $13.00
  • AVG Volume (30 Days)
  • KELYB 273.0
  • KMDA 77.9K
  • Earning Date
  • KELYB 08-07-2025
  • KMDA 08-13-2025
  • Dividend Yield
  • KELYB 2.44%
  • KMDA 2.57%
  • EPS Growth
  • KELYB N/A
  • KMDA 31.21
  • EPS
  • KELYB N/A
  • KMDA 0.28
  • Revenue
  • KELYB $4,451,600,000.00
  • KMDA $167,235,000.00
  • Revenue This Year
  • KELYB $8.06
  • KMDA $14.51
  • Revenue Next Year
  • KELYB $4.08
  • KMDA $9.31
  • P/E Ratio
  • KELYB N/A
  • KMDA $28.07
  • Revenue Growth
  • KELYB N/A
  • KMDA 11.83
  • 52 Week Low
  • KELYB $11.04
  • KMDA $5.08
  • 52 Week High
  • KELYB $22.98
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • KELYB 45.40
  • KMDA 69.39
  • Support Level
  • KELYB $12.06
  • KMDA $7.62
  • Resistance Level
  • KELYB $12.60
  • KMDA $7.92
  • Average True Range (ATR)
  • KELYB 0.00
  • KMDA 0.21
  • MACD
  • KELYB -0.01
  • KMDA 0.01
  • Stochastic Oscillator
  • KELYB 0.00
  • KMDA 83.18

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: